Treatment Advances Give Hope to People with Brain Metastases
Lisa VanTress didn’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016.
Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors
Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified.
Researchers Identify Promising New Drug Target for Lethal Prostate Cancer
Targeting a protein genome-binding process that directs expression of diverse cancerous genes could be an important new therapy approach for stopping the progression of late-stage prostate cancer,
Stages of Complex Grant Development (Part 2)
In the last post, I identified five stages for successful complex grant development.
Small Study Suggests a New Way to Treat Fluid Buildup in Heart Failure
Duke team challenges the paradigm about fluid as a symptom of heart failure
Smell Receptor Fuels Prostate Cancer Progression
When scientists first described the receptors responsible for our sense of smell, they naturally assumed that these chemical sensors resided exclusively in the lining of our noses.
Post Go Live Research Systems Update - May 2018
OnCore Community News
iRIS Community News
OnCore and iRIS are Live!
Clinical Research Day highlights the role of new technologies in building partnerships
Innovation Speaker, Tom Insel, MD